Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Coltene Holding AG's Other Operating Expense for the
six
months ended in Jun. 2026 was CHF67.6 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was CHF124.8 Mil.
Coltene Holding AG's quarterly Other Operating Expense
declined
from Jun. 2025 (CHF70.9 Mil) to Dec. 2025 (CHF57.3 Mil) but then
increased
from Dec. 2025 (CHF57.3 Mil) to Jun. 2026 (CHF67.6 Mil).
Coltene Holding AG's annual Other Operating Expense
increased
from Dec. 2023 (CHF96.4 Mil) to Dec. 2024 (CHF98.0 Mil) but then
declined
from Dec. 2024 (CHF98.0 Mil) to Dec. 2025 (CHF95.3 Mil).
Coltene Holding AG Other Operating Expense Related Terms
Coltene Holding AG Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF124.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of CHF124.8 Mil mean?
Coltene Holding AG (LTS:0QP7) has a Other Operating Expense of CHF124.8 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Coltene Holding AG and its competitors.
Is Coltene Holding AG's Other Operating Expense too high?
Coltene Holding AG's current Other Operating Expense is CHF124.8 Mil. Overall, Coltene Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's Other Operating Expense compare to ISRG and BDX?
Coltene Holding AG's Other Operating Expense of CHF124.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Coltene Holding AG and its competitors. Coltene Holding AG's current Other Operating Expense is CHF124.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (LTS:0QP7) is currently considered Fairly Valued. The stock's GF Value™ is CHF50.55, compared to a current price of CHF50.50 — trading 0.1% below its estimated fair value. The current Other Operating Expense is CHF124.8 Mil. Coltene Holding AG's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Coltene Holding AG (LTS:0QP7), the current Other Operating Expense is CHF124.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (LTS:0QP7) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF50.50 is trading 0.1% below its estimated GF Value™ of CHF50.55.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for LTS:0QP7:
Other Operating Expense: CHF124.8 Mil
GF Value™: CHF50.55 vs. price of CHF50.50 (0.1% below fair value)
No single metric tells the full story. See the LTS:0QP7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
74GF Score
Get the complete analysis for LTS:0QP7
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QP7 has been successfully added to your 
